iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model.
/PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that iNtRON has demonstrated the effectiveness of P18-BE3CRC using a...